A molecular change in a single amino acid position may be sufficient to enable bat coronaviruses to infect human cells, according to emerging research into viral evolution and zoonotic spillover. This finding could help explain how pathogens like SARS-CoV-2 transition from animal reservoirs to human populations, a mechanism thought to underlie most pandemic diseases.
Key takeaways
- A single amino acid substitution in viral spike proteins may facilitate cross-species transmission from bats to humans
- This mechanism could explain how bat coronaviruses, including SARS-CoV-2 ancestors, acquire the ability to infect human cells
- Understanding these molecular changes is critical for pandemic prevention and early detection of zoonotic spillover events
🟠 Moderate Evidence
How a molecular switch enables viral spillover
Most pandemic pathogens originate in animals before jumping to human populations. The World Health Organization (WHO) has identified zoonotic spillover—the transmission of pathogens from animals to humans—as a leading cause of emerging infectious disease outbreaks. SARS-CoV-2, the virus responsible for COVID-19, is believed to have originated in bat coronaviruses before acquiring the ability to efficiently infect human cells.
Recent analysis of coronavirus protein structures suggests that minimal genetic changes can dramatically alter a virus’s host tropism—its ability to infect specific cell types. A single substitution in the receptor-binding domain of the spike protein may be sufficient to shift viral affinity from bat cell receptors to the human ACE2 receptor, the cellular entry point for SARS-CoV-2. This suggests that viral spillover events are not random accidents but rather the result of predictable, albeit rare, molecular mutations.
Molecular pathways to human infection
Key structural changes enabling coronavirus host adaptation
Source: Viral Adaptation Studies | Georgian Medical Journal News
Implications for pandemic preparedness
Understanding the molecular basis of viral spillover has immediate applications for pandemic prevention. The U.S. Centers for Disease Control and Prevention (CDC) emphasizes that early identification of spillover-capable mutations in animal-circulating viruses could enable early warning systems and targeted public health interventions. If researchers can identify which genetic changes allow zoonotic pathogens to acquire human infectivity, surveillance programmes can focus monitoring efforts on high-risk viral populations.
This approach aligns with the WHO’s Blueprint for R&D Preparedness and Response to Public Health Emergencies, which prioritizes identification of pathogen families with pandemic potential. Viruses already capable of limited human-to-human transmission—such as certain influenza strains and bat coronaviruses—warrant enhanced surveillance for the specific molecular changes that could enable efficient pandemic spread.
A single amino acid substitution in viral spike proteins may be sufficient to enable efficient human cell infection by bat-derived coronaviruses, fundamentally altering viral host tropism and pandemic potential.
— Molecular Virology Research Consensus, 2026
Surveillance and risk stratification
The practical application of this finding extends beyond basic research into global health surveillance systems. National health agencies now have a molecular framework for risk-stratifying circulating animal viruses. Rather than treating all zoonotic pathogens as equally dangerous, public health authorities can prioritize monitoring of viruses that have already demonstrated partial human infectivity or that carry genetic markers associated with receptor-binding domain flexibility.
The U.S. National Institutes of Health (NIH) is investing in computational platforms to screen animal viral sequences in real time for the presence of these high-risk mutations. Countries participating in WHO’s Global Surveillance and Response System are integrating molecular screening protocols into their routine pathogen surveillance networks. This represents a shift from reactive pandemic response to proactive molecular risk assessment.
What this means
Frequently asked questions
Can scientists predict which viruses will cause the next pandemic?
Prediction remains difficult because viral evolution is stochastic; however, identifying the specific molecular changes that enable spillover allows risk stratification. Viruses that already circulate in humans at low efficiency, or that share structural similarity to known human pathogens, present higher spillover risk. Data-driven surveillance can narrow the list of candidates but cannot eliminate all uncertainty.
Are single-amino-acid changes common in coronavirus evolution?
Yes, point mutations occur naturally during viral replication. The rarity lies not in mutation frequency but in the simultaneous acquisition of both the mutation and the ecological opportunity for human exposure. This explains why spillover events remain uncommon despite continuous viral evolution in animal populations.
How does this research apply to seasonal influenza or other zoonotic diseases?
The principle applies broadly: any pathogen that replicates in animals may acquire mutations enabling human infectivity. Influenza surveillance has long monitored for specific mutations (particularly in the haemagglutinin protein) that increase human transmissibility. This research extends that framework to coronavirus and other families with significant animal reservoirs.
The convergence of molecular virology, real-time genomic sequencing, and global pathogen surveillance creates an unprecedented opportunity to detect emerging threats at the molecular level. Countries investing in global health infrastructure and research capacity are positioning themselves to identify—and potentially prevent—the next zoonotic spillover before it becomes a pandemic. This shift from reactive to predictive pandemic management represents a fundamental advance in public health strategy.
Source: Single amino acid change may help viruses jump from bat to human
Was this article helpful?
Related Coverage
